価格表

在庫・価格 : 2024年05月04日 04時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD34, Mouse-Mono(QBEnd/10)
データシート
NBP2-32932 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥91,000
(未発注)
追加

在庫・価格 : 2024年05月04日 04時57分 現在

Anti-CD34, Mouse-Mono(QBEnd/10)

  • 商品コード:NBP2-32932
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥91,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 AbuSamra DB et al. Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay. J. Biol. Chem. 2015 Aug;290(35):21213-30
AbuSamra DB et al
2015/01/01
Species: Human, Applications: WB PubMed
2 Aoki H et al. Efficient differentiation and purification of human induced pluripotent stem cell-derived endothelial progenitor cells and expansion with the use of inhibitors of ROCK, TGF-β, and GSK3β. Heliyon 2020 Mar;6(3):e03493
Aoki H et al
2020/01/01
PubMed
3 Xu Z et al. Effects of shRNA-mediated silencing of PDE5A3 on intracellular cGMP and free Ca<sup>2+</sup> levels and human prostate smooth muscle cell proliferation from benign prostatic hyperplasia. Exp Ther Med 2021 Apr;21(4):322
Xu Z et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    AbuSamra DB et al. Quantitative Characterization of E-selectin Interaction with Native CD44 and P-selectin Glycoprotein Ligand-1 (PSGL-1) Using a Real Time Immunoprecipitation-based Binding Assay. J. Biol. Chem. 2015 Aug;290(35):21213-30
    AbuSamra DB et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Aoki H et al. Efficient differentiation and purification of human induced pluripotent stem cell-derived endothelial progenitor cells and expansion with the use of inhibitors of ROCK, TGF-&#x3B2;, and GSK3&#x3B2;. Heliyon 2020 Mar;6(3):e03493
    Aoki H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Xu Z et al. Effects of shRNA-mediated silencing of PDE5A3 on intracellular cGMP and free Ca<sup>2+</sup> levels and human prostate smooth muscle cell proliferation from benign prostatic hyperplasia. Exp Ther Med 2021 Apr;21(4):322
    Xu Z et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed